Evolution Summit 2013
October 21 - 23, 2013
Monte Carlo , Monaco
The 12th annual Evolution Summit is a premium forum bringing together leaders in biopharmaceutical clinical operations with the most renowned CROs and solution providers.
As an invitation-only event taking place behind closed doors, the summit offers an intimate environemtn for a focused discussion of key new drivers shaping drug development strategies.
Key Topics
Drastic Measures – Shedding light on the regulatory, market access and comparative efficacy hurdles transforming R&D
Lost in Translation – Defining PoC to determine the relevant data requirements and accelerate early development
Keeping Success in Site – Optimising site selection, management and monitoring strategies to secure quality clinical data
Shaking up the Status Quo – Challenging the conventional with innovations in regenerative medicine, gene and cell therapy as a potential cure for pharma’s productivity crisis
Defining Quality of Life – Assessing drug candidate value from a pricing perspective to enhance clinical decision-making
Mutual Missions – Aligning sponsor, CRO and CRA priorities to reap the rewards of a successful trial
Recruiting Responders – Going beyond database screening to cut recruitment costs, increase sample sizes and deliver the right therapy to the right patient
Lifting the Feasibility Veil – Building productive and transparent CRO relationships to close the gap between expectations and realities
Going Global without Going Loco – Examining the idiosyncrasies of emerging markets for a robust worldwide strategy
As an invitation-only event taking place behind closed doors, the summit offers an intimate environemtn for a focused discussion of key new drivers shaping drug development strategies.
Key Topics
Drastic Measures – Shedding light on the regulatory, market access and comparative efficacy hurdles transforming R&D
Lost in Translation – Defining PoC to determine the relevant data requirements and accelerate early development
Keeping Success in Site – Optimising site selection, management and monitoring strategies to secure quality clinical data
Shaking up the Status Quo – Challenging the conventional with innovations in regenerative medicine, gene and cell therapy as a potential cure for pharma’s productivity crisis
Defining Quality of Life – Assessing drug candidate value from a pricing perspective to enhance clinical decision-making
Mutual Missions – Aligning sponsor, CRO and CRA priorities to reap the rewards of a successful trial
Recruiting Responders – Going beyond database screening to cut recruitment costs, increase sample sizes and deliver the right therapy to the right patient
Lifting the Feasibility Veil – Building productive and transparent CRO relationships to close the gap between expectations and realities
Going Global without Going Loco – Examining the idiosyncrasies of emerging markets for a robust worldwide strategy
Related events
Evolution Summit October 21 - 23, 2015
Evolution Summit May 8 - 10, 2015
Evolution Summit October 20 - 22, 2014
Evolution Summit October 21 - 23, 2013
Evolution Summit May 8 - 10, 2013
Evolution Summit April 30 - May 2, 2012
Evolution Summit May 4 - 6, 2011